Literature DB >> 23222735

Systemic human T cell developmental processes in humanized mice cotransplanted with human fetal thymus/liver tissue and hematopoietic stem cells.

Sung-Yeon Joo1, Yun Shin Chung, Bongkum Choi, Miyoung Kim, Jong-Hwa Kim, Tae-Gook Jun, Jun Chang, Jonathan Sprent, Charles D Surh, Jae-won Joh, Sung Joo Kim.   

Abstract

BACKGROUND: In many humanized mouse models, there are few T cells in the engrafted human cell, whereas the number of B cells is high. We attempted to overcome this limitation and investigate whether the entire process of human T cell development arose similarly to the process in humans, as previously reported.
METHODS: To produce an advanced humanized mice model, we transplanted human fetal liver/thymus tissue subrenally and injected human CD34(+) stem cells intravenously into NOD/SCID/IL2Rgamma null (NSG) mice.
RESULTS: Humanized mice transplanted with fetal thymus/liver tissues and fetal liver-derived CD34(+) stem cells (FLT+FLCD34) showed higher levels of human cells and T cells than mice transplanted with fetal liver-derived CD34(+) stem cells only (FLCD34). In the transplanted thymus tissue of FLT+FLCD34 mice, thymus seeding progenitors (TSPs), early thymic progenitors (ETPs), pre-T cells, and all the other human T cell populations were identified. In the periphery, FLT+FLCD34 mice have high levels of CD45RA(+) T cells; conversely, FLCD34 mice have higher levels of CD45RO(+) T cells. The CD45RO(+) T cells of FLCD34 mice proliferated rapidly after stimulation and exhibited innate T cells properties, expressing PLZF (promyelocytic leukemia zinc finger protein).
CONCLUSION: Human T cells educated by mouse MHC II in mice without a human thymus differ from normal human T cells. On the basis of these findings, numerous T cell-tropic human diseases could be explored in our humanized mice and molecular aspects of human T cell development could be also studied extensively.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23222735     DOI: 10.1097/TP.0b013e318270f392

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

1.  Human immune system development and survival of non-obese diabetic (NOD)-scid IL2rγ(null) (NSG) mice engrafted with human thymus and autologous haematopoietic stem cells.

Authors:  L Covassin; S Jangalwe; N Jouvet; J Laning; L Burzenski; L D Shultz; M A Brehm
Journal:  Clin Exp Immunol       Date:  2013-12       Impact factor: 4.330

Review 2.  Humanized mice: novel model for studying mechanisms of human immune-based therapies.

Authors:  Louis Gonzalez; Natasa Strbo; Eckhard R Podack
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

3.  Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell Phenotypes.

Authors:  Juan A Marín-Jiménez; Anna Capasso; Matthew S Lewis; Stacey M Bagby; Sarah J Hartman; Jeremy Shulman; Natalie M Navarro; Hui Yu; Chris J Rivard; Xiaoguang Wang; Jessica C Barkow; Degui Geng; Adwitiya Kar; Ashley Yingst; Dejene M Tufa; James T Dolan; Patrick J Blatchford; Brian M Freed; Raul M Torres; Eduardo Davila; Jill E Slansky; Roberta Pelanda; S Gail Eckhardt; Wells A Messersmith; Jennifer R Diamond; Christopher H Lieu; Michael R Verneris; Jing H Wang; Katja Kiseljak-Vassiliades; Todd M Pitts; Julie Lang
Journal:  Front Immunol       Date:  2021-03-29       Impact factor: 7.561

Review 4.  Application of Humanized Mice in Immunological Research.

Authors:  Wenwei Tu; Jian Zheng
Journal:  Methods Mol Biol       Date:  2016

Review 5.  Humanized Mice as an Effective Evaluation System for Peptide Vaccines and Immune Checkpoint Inhibitors.

Authors:  Yoshie Kametani; Yusuke Ohno; Shino Ohshima; Banri Tsuda; Atsushi Yasuda; Toshiro Seki; Ryoji Ito; Yutaka Tokuda
Journal:  Int J Mol Sci       Date:  2019-12-16       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.